Hang et al. [4], examining the level of metalloproteinases in melanoma cells (B16-F10), found that the anticancer mechanism of hinokitiol may be related to blocking the signaling pathways and transcription factors NF-κB and c-Jun. Here, NFKB1 is linked to melanoma.